Elderly of 65 years and older with geriatric giant problems Dutch: Ouderen van 65 jaar of ouder met geriatrische reuzen problematiek
Conditions
Interventions
Intervention group
An external expert team consisting of an assistant, a general practitioner and a pharmacist will carry out the medication review of every participating patient in the intervention
Sponsors
VU Medical Center and NIVEL
Eligibility
Inclusion criteria
Inclusion criteria: One or more of the following new geriatric giants: 1. Actual mobility problem; 2. Two falls or more in the last 6 months; 3. One fall in the last 6 months and a score on the visual analogue scale for Fear of Falling (VAS-FOF) of 5 or more; 4. Dizziness; 5. Urinary incontinence; 6. Problems with cognition. The geriatric giants identification is a two-step approach: 1. Identification by ICPC codes in GP registration system. Every 8 weeks patients who consulted the GP with a relevant diagnosis in this time period and did not present the problem to the GP during the previous 12 months will be invited to participate. 2. Self-report by patients of the presence of at least one geriatric giant (5 or more on a scale of 1-10) Additionally they have to indicate that they are willing to participate in the trial by signing an informed consent form.
Exclusion criteria
Exclusion criteria: - All patients with a diagnosis of dementia in the medical record. - Patients with an MMSE score of 18 or less. An MMSE interview is only carried out when patients indicated they needed help to fill in the inclusion questionnaire. - A terminal illness leading to an expected death within six months. - Not willing or unable to participate in studies trials according to GPs. - Received a systematic medication review according to polypharmacy Dutch guidelines in the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Quality of Life as assessed with EQ5D and SF12 by the patient and with the EQ5D by proxies. 2. The presence of geriatric giants on a scale from 1-10. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Number of drug related problems - Medication satisfaction - Medication adherence - Cost effectiveness - Surplus value of the patient participation on the outcome of the medication advice - Follow-up of the medication advice by GP and patient - Process analysis on succes and failure factors | — |
Contacts
Public ContactFloor Willeboordse
Van der Boechorstraat 7, room D550
Outcome results
None listed